The Latin American Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 4, 2025

November 4, 2025

Day One Reports Third Quarter 2025 Financial Results and Corporate Progress

GlobeNewswire

November 4, 2025

Blazpay Phase 3 Goes Live - Maximize Your Earnings with Blazpay's Referral Rewards in 2025's Best 1000x Crypto Presale

GlobeNewswire

November 4, 2025

10x, startup neerlandés, sale de modo sigiloso con su ‘AI Recruiter’

EIN Presswire

November 4, 2025

Deportation Lawyer Jorge Munoz Guides Immigrants Through Rapidly Changing Immigration Laws

EIN Presswire

November 4, 2025

Rivus Pharmaceuticals Presents Preclinical Data for Controlled Metabolic Accelerator (CMA) Pipeline Showing Fat-Selective, Muscle-Preserving Weight Loss in Obesity at ObesityWeek®

GlobeNewswire

November 4, 2025

Hengrui Pharma and Kailera Therapeutics Announce Additional Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531

GlobeNewswire

November 4, 2025

Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025

GlobeNewswire

November 4, 2025

Le projet d'antimoine Bald Hill, sous option auprès de Globex, indique un potentiel de 2,7 millions de tonnes de 3 % à 4 % Sb.

GlobeNewswire

November 4, 2025

Bald Hill Antimony Project Under Option From Globex Indicates Potential for 2.7 M Tonnes at 3% to 4% Sb

GlobeNewswire

November 4, 2025

Direct Online Marketing Announces ‘Budget Smarter: 2026 Digital Marketing by the Numbers’ Webinar

EIN Presswire

November 4, 2025

Mining Right Granted and Executed for Zeb Nickel

GlobeNewswire

November 4, 2025

Enara Bio’s DARKFOX Discovery Propels ENA101, the First Ever Bispecific T Cell Engager Targeting a Cancer-Specific Dark Antigen, into IND-Enabling Studies

GlobeNewswire

November 4, 2025

AIM ImmunoTech Announces Late Breaking Abstract from University of Pittsburgh Medical Center Accepted for Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting

GlobeNewswire

November 4, 2025

Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

GlobeNewswire

November 4, 2025

RESET™ Clinical Trial Demonstrates Superior Pain Relief with SPRINT® PNS Compared to Standard Interventional Management for Chronic Low Back Pain

GlobeNewswire

November 4, 2025

Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

GlobeNewswire

November 4, 2025

PDAC announces 2026 Awards recipients

GlobeNewswire

November 4, 2025

RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th

GlobeNewswire

November 4, 2025

Aligos Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire

November 4, 2025

Critical Metal Corp Obtains Crucial Environmental Approvals for the Tanbreez Project

GlobeNewswire